Literature DB >> 17623650

Fibromodulin binds collagen type I via Glu-353 and Lys-355 in leucine-rich repeat 11.

Sebastian Kalamajski1, Ake Oldberg.   

Abstract

Fibromodulin belongs to the small leucine-rich repeat proteoglycan family, interacts with collagen type I, and controls collagen fibrillogenesis and assembly. Here, we show that a major fibromodulin-binding site for collagen type I is located in leucine-rich repeat 11 in the C terminus of the leucine-rich repeat domain. We identified Glu-353 and Lys-355 in repeat 11 as essential for binding, and the synthetic peptide RLDGNEIKR, including Glu-353 and Lys-355, inhibits the binding of fibromodulin to collagen in vitro. Fibromodulin and lumican compete for the same binding region on collagen, and fibromodulin can inhibit the binding of lumican to collagen type I. However, the peptide RLDGNEIKR does not inhibit the binding of lumican to collagen, suggesting separate but closely situated fibromodulin- and lumican-binding sites in collagen. The collagen-binding Glu-353 and Lys-355 residues in fibromodulin are exposed on the exterior of the beta-sheet-loop structure of the leucine-rich repeat, which resembles the location of interacting residues in other leucine-rich repeat proteins, e.g. decorin.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17623650     DOI: 10.1074/jbc.M704026200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  The Tyrosine Sulfate Domain of Fibromodulin Binds Collagen and Enhances Fibril Formation.

Authors:  Viveka Tillgren; Matthias Mörgelin; Patrik Önnerfjord; Sebastian Kalamajski; Anders Aspberg
Journal:  J Biol Chem       Date:  2016-09-15       Impact factor: 5.157

2.  The tyrosine sulfate-rich domains of the LRR proteins fibromodulin and osteoadherin bind motifs of basic clusters in a variety of heparin-binding proteins, including bioactive factors.

Authors:  Viveka Tillgren; Patrik Onnerfjord; Lisbet Haglund; Dick Heinegård
Journal:  J Biol Chem       Date:  2009-08-21       Impact factor: 5.157

Review 3.  Biglycan in the Skeleton.

Authors:  Vardit Kram; Reut Shainer; Priyam Jani; Josephina A N Meester; Bart Loeys; Marian F Young
Journal:  J Histochem Cytochem       Date:  2020-07-06       Impact factor: 2.479

4.  Increased C-telopeptide cross-linking of tendon type I collagen in fibromodulin-deficient mice.

Authors:  Sebastian Kalamajski; Cuiping Liu; Viveka Tillgren; Kristofer Rubin; Åke Oldberg; Jyoti Rai; MaryAnn Weis; David R Eyre
Journal:  J Biol Chem       Date:  2014-05-21       Impact factor: 5.157

5.  Regulation of collagen fibrillogenesis by cell-surface expression of kinase dead DDR2.

Authors:  Angela R Blissett; Derek Garbellini; Edward P Calomeni; Cosmin Mihai; Terry S Elton; Gunjan Agarwal
Journal:  J Mol Biol       Date:  2008-10-30       Impact factor: 5.469

6.  Long noncoding RNA Bmncr regulates mesenchymal stem cell fate during skeletal aging.

Authors:  Chang-Jun Li; Ye Xiao; Mi Yang; Tian Su; Xi Sun; Qi Guo; Yan Huang; Xiang-Hang Luo
Journal:  J Clin Invest       Date:  2018-10-22       Impact factor: 14.808

Review 7.  Small leucine-rich repeat proteoglycans in corneal inflammation and wound healing.

Authors:  Jihane Frikeche; George Maiti; Shukti Chakravarti
Journal:  Exp Eye Res       Date:  2016-08-26       Impact factor: 3.467

8.  Susceptibility to glaucoma damage related to age and connective tissue mutations in mice.

Authors:  Matthew R Steinhart; Elizabeth Cone-Kimball; Cathy Nguyen; Thao D Nguyen; Mary E Pease; Shukti Chakravarti; Ericka N Oglesby; Harry A Quigley
Journal:  Exp Eye Res       Date:  2013-12-22       Impact factor: 3.467

Review 9.  The regulatory roles of small leucine-rich proteoglycans in extracellular matrix assembly.

Authors:  Shoujun Chen; David E Birk
Journal:  FEBS J       Date:  2013-02-14       Impact factor: 5.542

10.  Transcriptome profiles of carcinoma-in-situ and invasive non-small cell lung cancer as revealed by SAGE.

Authors:  Kim M Lonergan; Raj Chari; Bradley P Coe; Ian M Wilson; Ming-Sound Tsao; Raymond T Ng; Calum Macaulay; Stephen Lam; Wan L Lam
Journal:  PLoS One       Date:  2010-02-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.